Show simple item record

dc.contributor.authorMorrison, Joanne
dc.date.accessioned2019-06-26T19:51:41Z
dc.date.available2019-06-26T19:51:41Z
dc.date.issued2019-03-08
dc.identifier.urihttp://hdl.handle.net/10713/9834
dc.descriptionEach year there are nearly 11 million cases of typhoid, a disease that is spread through contaminated food, drink and water. Researchers at the University of Maryland School of Medicine are leading an international consortium that is studying the impact of a typhoid conjugate vaccine (TCV) in an effort to accelerate introduction of the vaccine in countries in sub-Saharan Africa and Asia where there is a high burden of typhoid.en_US
dc.language.isoen_USen_US
dc.subjectUniversity of Maryland, Baltimore. School of Medicine. Center for Vaccine Developmenten_US
dc.subjectTyphoid Vaccine Acceleration Consortiumen_US
dc.subject.meshTyphoid-Paratyphoid Vaccinesen_US
dc.subject.meshAfrica South of the Saharaen_US
dc.subject.meshAsiaen_US
dc.titleUMSOM Researchers Unveil Progress and Challenges in Introducing Typhoid Conjugate Vaccine in Sub-Saharan Africa and Asiaen_US
dc.typeArticleen_US
refterms.dateFOA2019-06-26T19:51:41Z


Files in this item

Thumbnail
Name:
TyphoidConjugateVaccineProgres ...
Size:
395.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record